Routes of non-traditional entry into buprenorphine treatment programs

Abstract

Background: Excessive prescribing, increased potency of opioids, and increased availability of illicit heroin and synthetic analogs such as fentanyl has resulted in an increase of overdose fatalities. Medications for opioid use disorder (MOUD) significantly reduces the risk of overdose when compared with no treatment. Although the use of buprenorphine as an agonist treatment for opioid use disorder (OUD) is growing significantly, barriers remain which can prevent or delay treatment. In this study we examine non-traditional routes which could facilitate entry into buprenorphine treatment programs. Methods: Relevant, original research publications addressing entry into buprenorphine treatment published during the years 1989-2019 were identified through PubMed, PsychInfo, PsychArticles, and Medline databases. We operationalized key terms based on three non-traditional paths: persons that entered treatment via the criminal justice system, following emergencies, and through community outreach. Results: Of 462 screened articles, twenty studies met the inclusion criteria for full review. Most studies were from the last several years, and most (65%) were from the Northeastern region of the United States. Twelve (60%) were studies suggesting that the criminal justice system could be a potentially viable entry route, both pre-release or post-incarceration. The emergency department was also found to be a cost-effective and viable route for screening and identifying individuals with OUD and linking them to buprenorphine treatment. Fewer studies have documented community outreach initiatives involving buprenorphine. Most studies were small sample size (mean = < 200) and 40% were randomized trials. Conclusions: Despite research suggesting that increasing the number of Drug Addiction Treatment Act (DATA) waived physicians who prescribe buprenorphine would help with the opioid treatment gap, little research has been conducted on routes to increase utilization of treatment. In this study, we found evidence that engaging individuals through criminal justice, emergency departments, and community outreach can serve as non-traditional treatment entry points for certain populations. Alternative routes could engage a greater number of people to initiate MOUD treatment.

Demystifying the Dark Web Opioid Trade: Content Analysis on Anonymous Market Listings and Forum Posts

“…When interpreted by professionals, our initial results demonstrate useful findings and may be used downstream by law enforcement and public policy makers for impactful structural interventions to the opioid crisis. Although a large body of current research is focused on pathways for treatment of opioid use disorder and analyzing deaths per treatment capacity of substance use providers, these research areas are limited to the demand side of the opioid epidemic [40,41]. We believe that the findings and pattern analyses presented here, which place concentration on the supply side, might suggest a new direction to focus and will serve as a useful complement to current research conducted within the domain of addiction medicine.…”

Prevalence of Mental Health Disorders among Individuals Enrolled in an Emergency Response Program for Treatment of Opioid Use Disorder

“…32 Although there is an abundance of research on SUD and mental health comorbidity, most research to date specifically examining opioid use disorder and co-occurring mental health diagnoses has specifically focused on different subgroups of populations (e.g. inpatient treatment, criminal justice, population surveys) 60,61 or already registered in a SUD treatment program. 36,40,41 There have been prior studies estimating the prevalence of dual diagnoses.…”

Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder

“…The U.S. model of methadone treatment is characterized by strict regulations and high-threshold approaches that have demanding entry requirements, are abstinence-centric, require frequent urine drug tests, and mandate psychosocial support. Evidence suggests that nontraditional settings allow access to a broader, often more marginalized patient population that can result in increased initiation and retention rates and decreases in opioid use ( Bachhuber et al, 2018 ; Champagne-Langabeer et al, 2020 ; Hall et al, 2014 ; Krawczyk et al, 2019 ) by offering recovery supports to reduce illicit drug use without mandating abstinence to receive MOUD ( Payne et al, 2019 ; Snow et al, 2019 ; Weinstein et al, 2010 ; Weinstein et al, 2017 ).…”